Updated analysis of a phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation therapy oncology group trial 9514

被引:0
|
作者
Kraybill, W. G. [1 ]
Harris, I. J. [2 ,3 ]
Spiro, I. J. [3 ]
Ettinger, D. S. [4 ]
Letson, G. D. [5 ]
DeLaney, T. F.
Blum, R. H. [6 ]
Lucas, D. R. [7 ]
Harmon, D. C.
Eisenberg, B. [8 ]
机构
[1] Univ Missouri, St Lukes Hosp, Kansas City, MO USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Johns Hopkins Oncol Ctr, Baltimore, MD USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[6] Beth Israel Hosp Canc Ctr, New York, NY USA
[7] Univ Michigan, Hlth Sci Ctr, Ann Arbor, MI USA
[8] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [41] Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology Group
    Million, Lynn
    Hayes-Jordan, Andrea
    Chi, Yueh-Yun
    Donaldson, Sarah S.
    Wolden, Suzanne
    Morris, Carol
    Terezakis, Stephanie
    Laurie, Fran
    Morano, Karen
    Fitzgerald, T. J.
    Yock, Torunn I.
    Rodeberg, David A.
    Anderson, James R.
    Speights, Rose Anne
    Black, Jennifer O.
    Coffin, Cheryl
    McCarville, Mary Beth
    Kao, Simon C.
    Hawkins, Douglas S.
    Spunt, Sheri L.
    Randall, R. Lor
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (03): : 821 - 830
  • [42] A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes
    Nikitas, J.
    Kendal, J.
    Savjani, R. R.
    Jackson, N. J.
    Deng, J.
    Hernandez, J.
    Chong, N.
    Kadera, B.
    Crompton, J.
    Wessel, L.
    Chmielowski, B.
    Singh, A. S.
    Nelson, S. D.
    Dry, S. M.
    Weidhaas, J. B.
    Steinberg, M. L.
    Bernthal, N. M.
    Eilber, F. C.
    Kalbasi, A.
    Reddy, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S87 - S88
  • [43] A phase II trial evaluating efficacy of neo-/adjuvant EIA CTX, surgery, and radiation therapy in high-risk soft tissue sarcoma.
    Schmitt, T.
    Kasper, B.
    Bischof, M.
    Lehner, B.
    Dietrich, S.
    Dimitrakopoulou-Strauss, A.
    Strauss, L. G.
    Mechtersheimer, G.
    Wuchter, P.
    Ho, A. D.
    Egerer, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Evaluation of variables associated with outcomes in 41 dogs with incompletely excised high-grade soft tissue sarcomas treated with definitive-intent radiation therapy with or without chemotherapy
    Crownshaw, Abigail H.
    McEntee, Margaret C.
    Nolan, Michael W.
    Gieger, Tracy L.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2020, 256 (07): : 783 - 791
  • [45] Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled Trial
    Wang, Chunmeng
    Hu, Xianglin
    Yang, Lingge
    Xu, Yu
    Zheng, Biqiang
    Yang, Jilong
    Liao, Zhichao
    Sun, Zhengwang
    Zhang, Shengjian
    Yu, Lin
    Yan, Yan
    Chen, Yong
    Fujiwara, Tomohiro
    Zhang, Jianrong
    Buhtoiarov, Ilia N.
    Sun, Yangbai
    Yan, Wangjun
    CLINICAL CANCER RESEARCH, 2025, 31 (07) : 1194 - 1203
  • [46] Preoperative hypofractionated radiotherapy (RT) combined with chemotherapy in primary marginally resectable high grade soft tissue sarcomas (STS) of extremities or trunk wall: Interim analysis of prospective phase II clinical trial
    Spalek, M.
    Paterczyk, H. M. Kosela
    Borkowska, A.
    Wagrodzki, M.
    Cieszanowski, A.
    Castaneda-Wysocka, P.
    Switaj, T.
    Dudzisz-Sledz, M. E.
    Czarnecka, A. M.
    Dabrowska-Szewczyk, E.
    Rutkowski, P. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 585 - 586
  • [47] Phase 1 Adaptive Dose-Finding Study of Neoadjuvant Gemcitabine Combined With Radiation Therapy for Patients With High-Risk Extremity and Trunk Soft Tissue Sarcoma
    Tseng, William W.
    Zhou, Shouhao
    To, Christina A.
    Thall, Peter F.
    Lazar, Alexander J.
    Pollock, Raphael E.
    Lin, Patrick P.
    Cormier, Janice N.
    Lewis, Valerae O.
    Feig, Barry W.
    Hunt, Kelly K.
    Ballo, Matthew T.
    Patel, Shreyaskumar
    Pisters, Peter W. T.
    CANCER, 2015, 121 (20) : 3659 - 3667
  • [48] Histology and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
    Casali, P. G.
    Stacchiotti, S.
    Verderio, P.
    Collini, P.
    Tos, A. P. Dei
    Alberghini, M.
    Llombart-Bosch, A.
    Morosi, C.
    Messina, A.
    Mercuri, M.
    Gronchi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] The sarculator stratified prognosis of patients with high-risk soft tissue sarcomas (STS) of extremities and trunk wall treated with perioperative chemotherapy in a randomised controlled trial (RCT).
    Pasquali, Sandro
    Colombo, Chiara
    Bottelli, Stefano
    Verderio, Paolo
    Broto, Javier Martin
    Lopez-Pousa, Antonio
    Ferrari, Stefano
    Poveda, Andres
    De Paoli, Antonino
    Quagliuolo, Vittorio
    Cruz, Josefina
    Comandone, Alessandro
    Grignani, Giovanni
    De Sanctis, Rita
    Palassini, Elena
    Llombart-Bosch, Antonio
    Dei Tos, Angelo Paolo
    Casali, Paolo Giovanni
    Picci, Piero
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
    Pasquali, Sandro
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Martin-Broto, Javier
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Tendero, Oscar
    Diaz-Beveridge, Robert
    Ferraresi, Virginia
    Lugowska, Iwona
    Infante, Gabriele
    Braglia, Luca
    Merlo, Domenico Franco
    Fontana, Valeria
    Marchesi, Emanuela
    Donati, Davide Maria
    Palassini, Elena
    Bianchi, Giuseppe
    Marrari, Andrea
    Morosi, Carlo
    Stacchiotti, Silvia
    Bague, Silvia
    Coindre, Jean Michel
    Dei Tos, Angelo Paolo
    Picci, Piero
    Bruzzi, Paolo
    Miceli, Rosalba
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    CANCER, 2022, 128 (01) : 85 - 93